C07D 253/10
Condensed 1,2,4-triazines
Official title: Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
C07D253/10 (Condensed 1,2,4-triazines) appears on 60 US grants and 43 published applications in this corpus.
Search patents in C07D- Granted patents
- 60
- Published applications
- 43
- Assignees
- 43
- Inventors
- 166
- Latest grant
- 16 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 2 |
| 2004 | 2 | 1 |
| 2005 | 1 | 4 |
| 2006 | 1 | 2 |
| 2007 | 1 | 5 |
| 2008 | 1 | 3 |
| 2009 | 0 | 3 |
| 2010 | 2 | 2 |
| 2011 | 2 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 5 |
| 2014 | 4 | 3 |
| 2015 | 3 | 1 |
| 2016 | 3 | 5 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Organic compounds and organic light emitting display device using the same16 Dec 2025US 12,497,369 B2Lapto Co., Ltd.
- Cyclic triazo and diazo sodium channel blockers9 Jan 2018US 9,862,691 B2University of Greenwich
- Benzotriazine oxides as drugs targeting Mycobacterium tuberculosis30 May 2017US 9,663,478 B2SRI International
- Cyclic triazo and diazo sodium channel blockers23 Aug 2016US 9,422,253 B2University of Greenwich
- Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors14 Jun 2016US 9,364,481 B2Nivalis Therapeutics, Inc.
- New Coolants, and Preparations Containing Same22 May 2025US 2025/0163006 A1Symrise AG
- Organic compounds and organic light emitting display device using the same1 Jul 2021US 2021/0198212 A1Lapto Co., Ltd.
- Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis3 Aug 2017US 2017/0217908 A1SRI International
- Cyclic triazo and diazo sodium channel blockers27 Oct 2016US 2016/0311784 A1University of Greenwich
- Triazine mediated living radical controlled polymerization27 Oct 2016US 2016/0311785 A1Dow Global Technologies LLC
Most cited
By later US patents
- Vasculostatic agents and methods of use thereof47US 7,208,493 B2TargeGen, Inc. · 2007
- 1,2,4-Benzotriazine-1,4-di-N-oxide derivatives30US 4,160,833 ACiba-Geigy Corporation · 1979
- Process for preparing 1,2,4-benzotriazine oxides30US 5,175,287 AS R I International · 1992
- (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity30US 5,912,243 AZeneca Limited · 1999
- 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents29US 5,849,738 ASRI International · 1998